**Key Developments** - JD Industrials (07618) plans a global offering of 211 million shares, with an expected listing date of December 11. - CHINA GAS HOLD (00384) reaffirms its "Green City Operator" strategy, building a multi-energy complementary ecosystem, and enters a strategic cooperation agreement with Eve Energy. - CNNC INT'L (02302) sees its indirect parent company China Uranium officially list on the Shenzhen Stock Exchange, highlighting its strengthened capital market position. - Innoscience (02577) signs a strategic cooperation agreement with ON Semiconductor to jointly accelerate the development of the gallium nitride (GaN) industry ecosystem. - Innoscience (02577) wins its patent litigation case against Infineon, with the ITC ruling no infringement on two disputed patents. - Wangshan Wangshui-B (02630) signs a licensing agreement with Simcere Pharmaceutical (02096) for new indications of VV116. - SINO BIOPHARM (01177): Rotigotine transdermal patch approved for market launch. - Antengene-B (06996): Xpovio® approved in Hong Kong for two additional indications—multiple myeloma and diffuse large B-cell lymphoma. - Acotec Scientific-B (06669): Microcatheter V-otter’s registration application approved by China’s NMPA. - Jacobio-B (02617): Tisletyginib tablets included in the NMPA’s priority review list. - Yuexiu Transport Infrastructure (01052) plans to acquire an 85% stake in Shandong Qinbin Expressway for RMB 1.1535 billion.

**Share Buybacks/Stake Changes** - Tencent (00700) repurchases 1.04 million shares for HKD 636 million on December 3. - Xiaomi (01810) spends ~HKD 302 million to buy back 7.5 million shares on December 3. - Midea Group (00300) repurchases 1.2127 million A-shares for RMB 99.9984 million on December 3. - SF Holdings (06936) buys back 1.6386 million A-shares for RMB 62.1907 million on December 3. - COSCO SHIPPING Holdings (01919) repurchases 3 million shares for HKD 41.3725 million on December 3. - China Feihe (06186) spends HKD 16.7927 million to repurchase 4 million shares on December 3. - Ascletis Pharma-B (01672) repurchases 1.306 million shares for HKD 15.9275 million on December 3. - Fenbi (02469) buys back 453,050 shares for HKD 14.359 million on December 3. - Jolly Elite (08017): Chairman & Executive Director Liu Yong increases stake by 1 million shares. - ImmuneOnco-B (01541): Executive Director Tian Wenzhi acquires 50,000 H-shares. - Dongfang Electric (01072): Senior VP Wang Jun plans to sell up to 6,250 shares. - Red Star Macalline (01528): Shareholder Hangzhou Haoyue intends to sell up to ~131 million shares.

**Operational Performance** - Agile Group (03383) reports contracted sales of ~RMB 8.08 billion for the first 11 months, down 45.2% YoY.